hydroxychloroquine has been researched along with minocycline in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Caspi, D; Elkayam, O; Segal, R; Yaron, M; Zhukovsky, G | 1 |
| Blakely, KW; Eckhoff, PJ; Fernandez, AM; Haire, CE; Klassen, LW; Leff, RD; Mallek, JA; Moore, GF; O'Dell, JR; Palmer, WR; Paulsen, GA; Sems, KM; Wees, SJ | 1 |
| Pisetsky, DS; St Clair, EW | 1 |
| Emery, P; Suarez-Almazor, M | 1 |
| Fritzsche, M | 1 |
| Miller, AV; Ranatunga, SK | 1 |
| Füessl, HS; Stiefelhagen, P | 1 |
| Bazakas, A; Ladizinski, B; Olsen, EA; Selim, MA | 1 |
| Dahmoush, L; Icardi, M; Lenert, P | 1 |
| Danaei, G; Desai, RJ; Kim, SC; Liao, KP; Schneeweiss, S; Solomon, DH | 1 |
| Armstrong, N; Chabriere, E; Raoult, D; Richez, M | 1 |
| Ben-Hur, T; Faissner, S; Gold, R; Hahn, JN; Haupeltshofer, S; Koch, M; Mahjoub, Y; Metz, LM; Mishra, M; Yong, VW | 1 |
| Kalogirou, EM; Sklavounou, A; Tosios, KI | 1 |
| Garg, VK; Gautam, CS; Gautam, SS; Singh, H | 1 |
7 review(s) available for hydroxychloroquine and minocycline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Progress in the treatment of rheumatoid arthritis.
Topics: Analgesics; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2001 |
Rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2003 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2012 |
ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review.
Topics: Acne Vulgaris; Angiography; Antibodies, Antineutrophil Cytoplasmic; Autoimmunity; Biopsy; Diagnosis, Differential; Humans; Hydroxychloroquine; Inflammation; Male; Minocycline; Neutrophils; Polyarteritis Nodosa; Prednisone; Systemic Vasculitis; Testis; Young Adult | 2013 |
Drug-associated hyperpigmentation of the oral mucosa: report of four cases.
Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal; Antirheumatic Agents; Biopsy; Female; Humans; Hydroxychloroquine; Hyperpigmentation; Imatinib Mesylate; Male; Middle Aged; Minocycline; Mouth Mucosa; Protein Kinase Inhibitors | 2018 |
Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection.
Topics: Anti-Infective Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; Minocycline; Pandemics; Pneumonia, Viral; Severity of Illness Index | 2020 |
1 trial(s) available for hydroxychloroquine and minocycline
| Article | Year |
|---|---|
Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine.
Topics: Adult; Aged; Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Minocycline; Serologic Tests; Treatment Outcome | 2001 |
8 other study(ies) available for hydroxychloroquine and minocycline
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Toxicity profile of dual methotrexate combinations with gold, hydroxychloroquine, sulphasalazine and minocycline in rheumatoid arthritis patients.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Gold; Humans; Hydroxychloroquine; Male; Middle Aged; Minocycline; Retrospective Studies; Sulfasalazine; Treatment Outcome | 1997 |
Chronic Lyme borreliosis at the root of multiple sclerosis--is a cure with antibiotics attainable?
Topics: Animals; Anti-Bacterial Agents; Borrelia burgdorferi Group; Chronic Disease; Drug Therapy, Combination; Humans; Hydroxychloroquine; Ixodes; Lyme Disease; Minocycline; Multiple Sclerosis; Prevalence; Seasons; Secondary Prevention; Tinidazole | 2005 |
[Do combinations with hydroxychloroquine help?].
Topics: Anti-Bacterial Agents; Antimalarials; Chronic Disease; Doxycycline; Drug Therapy, Combination; Humans; Hydroxychloroquine; Lyme Disease; Minocycline | 2012 |
Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Alopecia; Anti-Bacterial Agents; Azasteroids; Cicatrix; Dutasteride; Enzyme Inhibitors; Eyebrows; Female; Fibrosis; Forehead; Hospitals, University; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lichen Planus; Methotrexate; Middle Aged; Minocycline; Osteoporosis, Postmenopausal; Retrospective Studies; Scalp; Tacrolimus; Treatment Outcome | 2013 |
Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Certolizumab Pegol; Cohort Studies; Cyclophosphamide; Etanercept; Female; Humans; Hydroxychloroquine; Hypertension; Incidence; Infliximab; Male; Methotrexate; Middle Aged; Minocycline; Penicillamine; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sulfasalazine; Tumor Necrosis Factor-alpha | 2016 |
Simultaneous UHPLC-UV analysis of hydroxychloroquine, minocycline and doxycycline from serum samples for the therapeutic drug monitoring of Q fever and Whipple's disease.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Doxycycline; Drug Monitoring; Drug Stability; Humans; Hydroxychloroquine; Limit of Detection; Linear Models; Minocycline; Q Fever; Reproducibility of Results; Whipple Disease | 2017 |
Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?
Topics: Animals; B-Lymphocytes; Cell Proliferation; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Humans; Hydroxychloroquine; Lymphocyte Activation; Mice; Mice, Biozzi; Mice, Inbred C57BL; Minocycline; Multiple Sclerosis; Neurons; Neuroprotective Agents; T-Lymphocytes | 2018 |